vs
宣伟（SHW）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是宣伟的1.3倍（$7.2B vs $5.7B），Stryker Corporation净利率更高（11.8% vs 9.4%，领先2.4%），Stryker Corporation同比增速更快（11.4% vs 6.8%），过去两年Stryker Corporation的营收复合增速更高（16.9% vs -4.9%）
宣伟是总部位于美国俄亥俄州克利夫兰的涂料企业，主要从事涂料、地坪覆盖材料及相关产品的生产、分销与销售业务，业务覆盖全球超过120个国家，截至2024年按营收计为全球规模最大的涂料企业。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
SHW vs SYK — 直观对比
营收规模更大
SYK
是对方的1.3倍
$5.7B
营收增速更快
SYK
高出4.6%
6.8%
净利率更高
SYK
高出2.4%
9.4%
两年增速更快
SYK
近两年复合增速
-4.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $7.2B |
| 净利润 | $534.7M | $849.0M |
| 毛利率 | 49.1% | 64.5% |
| 营业利润率 | — | 25.2% |
| 净利率 | 9.4% | 11.8% |
| 营收同比 | 6.8% | 11.4% |
| 净利润同比 | 6.1% | 55.5% |
| 每股收益（稀释后） | $2.15 | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SHWSYK
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.6B | $7.2B | ||
| Q3 25 | $6.4B | $6.1B | ||
| Q2 25 | $6.3B | $6.0B | ||
| Q1 25 | $5.3B | $5.9B | ||
| Q4 24 | $5.3B | $6.4B | ||
| Q3 24 | $6.2B | $5.5B | ||
| Q2 24 | $6.3B | $5.4B |
净利润SHWSYK
| Q1 26 | $534.7M | — | ||
| Q4 25 | $476.8M | $849.0M | ||
| Q3 25 | $833.1M | $859.0M | ||
| Q2 25 | $754.7M | $884.0M | ||
| Q1 25 | $503.9M | $654.0M | ||
| Q4 24 | $480.1M | $546.0M | ||
| Q3 24 | $806.2M | $834.0M | ||
| Q2 24 | $889.9M | $825.0M |
毛利率SHWSYK
| Q1 26 | 49.1% | — | ||
| Q4 25 | 48.5% | 64.5% | ||
| Q3 25 | 49.2% | 63.6% | ||
| Q2 25 | 49.4% | 63.8% | ||
| Q1 25 | 48.2% | 63.8% | ||
| Q4 24 | 48.6% | 64.9% | ||
| Q3 24 | 49.1% | 64.0% | ||
| Q2 24 | 48.8% | 63.0% |
营业利润率SHWSYK
| Q1 26 | — | — | ||
| Q4 25 | 11.4% | 25.2% | ||
| Q3 25 | 16.7% | 18.7% | ||
| Q2 25 | 15.6% | 18.5% | ||
| Q1 25 | 12.3% | 14.3% | ||
| Q4 24 | 11.6% | 9.0% | ||
| Q3 24 | 21.4% | 19.7% | ||
| Q2 24 | 22.5% | 19.4% |
净利率SHWSYK
| Q1 26 | 9.4% | — | ||
| Q4 25 | 8.5% | 11.8% | ||
| Q3 25 | 13.1% | 14.2% | ||
| Q2 25 | 12.0% | 14.7% | ||
| Q1 25 | 9.5% | 11.1% | ||
| Q4 24 | 9.1% | 8.5% | ||
| Q3 24 | 13.1% | 15.2% | ||
| Q2 24 | 14.2% | 15.2% |
每股收益（稀释后）SHWSYK
| Q1 26 | $2.15 | — | ||
| Q4 25 | $1.91 | $2.20 | ||
| Q3 25 | $3.35 | $2.22 | ||
| Q2 25 | $3.00 | $2.29 | ||
| Q1 25 | $2.00 | $1.69 | ||
| Q4 24 | $1.90 | $1.41 | ||
| Q3 24 | $3.18 | $2.16 | ||
| Q2 24 | $3.50 | $2.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $216.9K | $4.0B |
| 总债务越低越好 | $11.7M | — |
| 股东权益账面价值 | $4.4M | $22.4B |
| 总资产 | $26.4M | $47.8B |
| 负债/权益比越低杠杆越低 | 2.64× | — |
8季度趋势，按日历期对齐
现金及短期投资SHWSYK
| Q1 26 | $216.9K | — | ||
| Q4 25 | $207.2M | $4.0B | ||
| Q3 25 | $241.5M | $3.3B | ||
| Q2 25 | $269.8M | $2.4B | ||
| Q1 25 | $199.8M | $2.3B | ||
| Q4 24 | $210.4M | $3.7B | ||
| Q3 24 | $238.2M | $3.9B | ||
| Q2 24 | $200.0M | $1.9B |
总债务SHWSYK
| Q1 26 | $11.7M | — | ||
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.7B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $9.2B | — | ||
| Q3 24 | $9.2B | — | ||
| Q2 24 | $9.0B | — |
股东权益SHWSYK
| Q1 26 | $4.4M | — | ||
| Q4 25 | $4.6B | $22.4B | ||
| Q3 25 | $4.4B | $21.8B | ||
| Q2 25 | $4.4B | $21.2B | ||
| Q1 25 | $4.1B | $20.9B | ||
| Q4 24 | $4.1B | $20.6B | ||
| Q3 24 | $4.2B | $20.1B | ||
| Q2 24 | $3.8B | $19.8B |
总资产SHWSYK
| Q1 26 | $26.4M | — | ||
| Q4 25 | $25.9B | $47.8B | ||
| Q3 25 | $26.2B | $47.1B | ||
| Q2 25 | $25.4B | $46.3B | ||
| Q1 25 | $24.6B | $46.0B | ||
| Q4 24 | $23.6B | $43.0B | ||
| Q3 24 | $24.0B | $43.8B | ||
| Q2 24 | $23.7B | $39.1B |
负债/权益比SHWSYK
| Q1 26 | 2.64× | — | ||
| Q4 25 | 2.10× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 2.17× | — | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | 2.22× | — | ||
| Q2 24 | 2.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.1B |
| 自由现金流经营现金流 - 资本支出 | — | $1.9B |
| 自由现金流率自由现金流/营收 | — | 26.1% |
| 资本支出强度资本支出/营收 | 2.4% | 3.7% |
| 现金转化率经营现金流/净利润 | — | 2.52× |
| 过去12个月自由现金流最近4个季度 | — | $4.3B |
8季度趋势，按日历期对齐
经营现金流SHWSYK
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $-61.1M | $250.0M | ||
| Q4 24 | $934.5M | $1.9B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.2B | $633.0M |
自由现金流SHWSYK
| Q1 26 | — | — | ||
| Q4 25 | $862.1M | $1.9B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $931.1M | $928.0M | ||
| Q1 25 | $-250.4M | $127.0M | ||
| Q4 24 | $634.5M | $1.7B | ||
| Q3 24 | $839.4M | $1.3B | ||
| Q2 24 | $952.0M | $481.0M |
自由现金流率SHWSYK
| Q1 26 | — | — | ||
| Q4 25 | 15.4% | 26.1% | ||
| Q3 25 | 17.5% | 22.3% | ||
| Q2 25 | 14.7% | 15.4% | ||
| Q1 25 | -4.7% | 2.2% | ||
| Q4 24 | 12.0% | 25.9% | ||
| Q3 24 | 13.6% | 23.7% | ||
| Q2 24 | 15.2% | 8.9% |
资本支出强度SHWSYK
| Q1 26 | 2.4% | — | ||
| Q4 25 | 4.1% | 3.7% | ||
| Q3 25 | 3.1% | 3.1% | ||
| Q2 25 | 2.9% | 3.0% | ||
| Q1 25 | 3.6% | 2.1% | ||
| Q4 24 | 5.7% | 4.1% | ||
| Q3 24 | 3.8% | 3.1% | ||
| Q2 24 | 4.0% | 2.8% |
现金转化率SHWSYK
| Q1 26 | — | — | ||
| Q4 25 | 2.29× | 2.52× | ||
| Q3 25 | 1.57× | 1.79× | ||
| Q2 25 | 1.47× | 1.26× | ||
| Q1 25 | -0.12× | 0.38× | ||
| Q4 24 | 1.95× | 3.54× | ||
| Q3 24 | 1.33× | 1.77× | ||
| Q2 24 | 1.35× | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SHW
暂无分部数据
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
